In the BioHarmony Drug Report Database

"Preview" Icon

Insulin glulisine

Apidra (insulin glulisine) is a protein pharmaceutical. Insulin glulisine was first approved as Apidra on 2004-04-16. It has been approved in Europe to treat diabetes mellitus.

 

Trade Name

 

Apidra
 

Common Name

 

insulin glulisine
 

ChEMBL ID

 

CHEMBL1201613
 

Indication

 

diabetes mellitus
 

Drug Class

 

Image (chem structure or protein)

Insulin glulisine structure rendering